Table 4.
Cancer-directed surgery | Chemotherapy | Radiotherapy | Homone therapy | |||||
---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | |
Age-group | ||||||||
<40 | 5,113 | 65% | 3,915 | 50% | 2,147 | 27% | 302 | 4% |
40-49 | 7,630 | 81% | 4,330 | 46% | 3,760 | 40% | 1,369 | 14% |
50-59 | 14,855 | 78% | 8,278 | 43% | 8,471 | 44% | 3,693 | 19% |
60-69 | 21,226 | 69% | 9,950 | 33% | 13,284 | 43% | 5,603 | 18% |
70-79 | 17,801 | 63% | 6,921 | 24% | 11,658 | 41% | 5,669 | 20% |
80+ | 10,831 | 62% | 2,315 | 13% | 4,070 | 23% | 3,706 | 21% |
Time since diagnosis | ||||||||
<1 year | 7,422 | 50% | 3,350 | 23% | 2,970 | 20% | 1,470 | 10% |
1-4.99 years | 27,804 | 67% | 13,831 | 33% | 17,746 | 43% | 8,457 | 20% |
5-9.99 years | 22,796 | 72% | 10,553 | 33% | 13,789 | 43% | 6,283 | 20% |
10+ years | 19,434 | 79% | 7,975 | 32% | 8,885 | 36% | 4,132 | 17% |
Total | 77,456 | 69% | 35,709 | 32% | 43,390 | 39% | 20,342 | 18% |
1at 31/12/2011; 2excluding non-melanoma skin cancer.